Prime Therapeutics, LLC

Eagan, MN Finance & insuranceNAICS 524290

Self-funded health planPlan year 2025Renews January
7,632Participants+8% vs. prior year
$18.1MEst. pharmacy spend / yrParticipants × national avg.
Jan 2027Next renewalPlan year begins January 1
#3 of 17Finance & insurance in MNBy participants

Overview

Prime Therapeutics, LLC sponsors a self-funded health plan that covered 7,632 participants in plan year 2025, up 8% from the prior year. The plan year starts in January. Alongside medical, its benefits filing reports life insurance, dental, vision, short-term disability, and more.

Plan type
ERISA welfare benefit plan, self-funded (benefits paid from employer assets or a trust)
Participants
7,632 · prior year 7,088
Plan year
Begins January 1 · next renewal January 2027
Health plans filed
Prime Therapeutics, LLC Welfare Benefit Plan, plan 501 (7,632 participants)
Broker compensation
$494K across insured contracts
MedicalLife insuranceDentalVisionShort-term disabilityPrepaid legalLong-term disabilitySeveranceDeath benefitsOther welfare benefits

Insurance carriers

Insured coverage reported on Schedule A. Self-funded medical claims aren't reported there.

CarrierCoverageCoveredPremiumBroker comp
Reliastar Life Insurance CompanyLife, Long-term disability12,041$6.0M$363K
Vision Service PlanVision5,017$1.2M$36K
Provident Life and Accident Insurance CompanyLong-term disability563$800K$51K
MetLife Legal PlansLegal956$207K$21K
Unum Life Insurance Company of AmericaLong Term Care67$99K$20K
Zurich American Insurance CompanyBusiness Travel Accident7,632——

Pharmacy benefit estimate

StreamRX estimate for a plan this size. Not based on this plan's claims.

$18.1M/ year

Estimated prescription spend: 7,632 participants × $2,371 national average per member. Usually higher once dependents are counted.

$470K–$1.2M/ year

Typical savings opportunity found in independent reviews of plans this size.

Brands with a generic available$138K–$344K
Lower-cost therapeutic alternatives$201K–$420K
Generic pricing vs. actual cost$87K–$261K
PBM contract terms$45K–$136K
The DOL's PBM fee disclosure rule first applies to this plan for the plan year beginning January 2028: semiannual PBM compensation reports and an annual audit right.

Form 5500 filing details

Filing
Form 5500 with Schedule A, plan year 2025
Plan sponsor
Prime Therapeutics, LLC
Sponsor EIN
26-0076803
Plan number
501
Filed with
U.S. Department of Labor (EBSA) via EFAST2

Verify this filing: search EIN 26-0076803 in the Department of Labor's EFAST2 Form 5500 search.

Retirement plan

Plan
Prime Therapeutics LLC 401(k) Plan
Type
401(k) plan
Participants
9,242

About this data

Source: Prime Therapeutics, LLC's Form 5500 filing for plan year 2025 and its Schedule A insurance reports, published by the U.S. Department of Labor. "Self-funded" means the filing reports benefits paid from employer assets or a trust, with no medical insurance contract or with a stop-loss contract. Pharmacy figures are StreamRX estimates based on national averages. StreamRX is not affiliated with Prime Therapeutics, LLC.

Request a correction · Methodology